Evidence map›Paper›PMID 8153405›Full record

ReviewRheumatic diseases clinics of North America1994

Systemic lupus erythematosus and pregnancy.

M Petri

Registry-linked trialAbstract readReview
In one paragraph

Review in Rheumatic diseases clinics of North America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00005436 (Lupus Cohort--Thrombotic Events and Coronary Artery Disease), which is not on this map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00005436 completednot on this map

Lupus Cohort--Thrombotic Events and Coronary Artery Disease

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran1991 to 1996ConditionsCardiovascular Diseases, Coronary Disease, Thrombosis, Heart Diseases
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy.Journal of perinatology : official journal of the California Perinatal Association · 2005
    Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

M PetriDivision of Molecular and Clinical Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Funding

Lupus CohortR01AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1997 to 2015
$8.2M
ZIDOVUDINE WITH PROBENECID--EFFECTS OF PROBENECID ON ZIDOVUDINEM01RR000722 · NCRR · JOHNS HOPKINS UNIVERSITY · PI MILLER, EDWARD D · 1985 to 1996
–
LUPUS COHORT-THROMBOTIC EVENTS &CORONARY ARTERY DISEASER29HL047080 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1991 to 1995
–
NCRR NIH HHS RR00722NHLBI NIH HHS HL47080-02NIAMS NIH HHS R01 AR043727
6 · The paper itself

Abstract

Although most women with systemic lupus erythematosus can achieve a successful pregnancy, fetal (fetal loss, preterm birth) and maternal (lupus flares, worsening renal function) morbidity remain major problems. Predictors of fetal loss and preterm birth have been identified and are reviewed. Modern management of lupus pregnancy includes identification of high-risk pregnancies with appropriate monitoring and treatment (when indicated) for anti-Ro and antiphospholipid antibodies, frequent assessment of and control of maternal lupus activity, adjustment of medications to avoid those associated with fetal teratogenicity, and the appropriate use of fetal assessment tests to guide intervention for the fetus at risk of intrauterine death.

Indexed as

Antibodies, AntiphospholipidAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAntimalarialsAntiphospholipid SyndromeFemaleFetal DeathGlucocorticoidsHumansImmunosuppressive AgentsKidney DiseasesLupus Erythematosus, SystemicObstetric Labor, PrematurePre-EclampsiaPregnancyPregnancy ComplicationsAntibodies, AntiphospholipidAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAntimalarialsGlucocorticoidsImmunosuppressive Agents

Identifiers

PMID8153405
PMCPMC5288842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.